TOP STORIES

• BUSINESS Pfizer Japan Takes Generic Contenders to Court over Lyrica Patent
  August 18, 2020

• ACADEMIA Generic APIs at Crossroads - 4: Professor Calls for Monitoring Drugs Liable to Be in Short Supply, Drawing Up Lists of Substitutes
  August 17, 2020

• ACADEMIA Generic APIs at Crossroads - 3: Gx Society Sets Up Committee for Discussions with Healthcare Providers and API Manufacturers
  August 14, 2020

• ORGANIZATION Generic APIs at Crossroads - 2: Traders’ Group Urges Simpler Regulatory Procedures to Facilitate API Substitution
  August 13, 2020

• BUSINESS Biosimilars Showing Accelerated Uptick in Japan, Doctor Fee Incentive as Tailwind
  August 12, 2020

• ORGANIZATION JMA’s New Pharma Affairs Exec Wants More Stringent Rules on Sakigake, Conditional Approval
  August 11, 2020

• REGULATORY AstraZeneca to Supply 120 Million Doses of COVID-19 Vaccine to Japan
  August 11, 2020

• BUSINESS Axcelead Chief Says Small-Molecule Drug Targets More than Doubled in Last Few Years; IPO Eyed in 4-5 Years
  August 7, 2020

• BUSINESS GSK, KM Biologics in Adjuvant Tech Transfer Talks for COVID-19 Vaccines
  August 7, 2020

• BUSINESS MSD Japan Chief Wants Talks with Govt, Re-Pricing Rules Revisited to Help Innovation Thrive
  August 6, 2020

• BUSINESS Celltrion Poised to Roll Out 20 Biosimilars in Japan over Next 10 Years
  August 5, 2020

• BUSINESS Povidone-Iodine Gargle Meds Fly Off Pharmacy Shelves after Osaka COVID-19 Data
  August 5, 2020

• BUSINESS Daiichi Sankyo to Curb Shipments for Herceptin Biosimilar on Surging Demand
  August 4, 2020

• BUSINESS BMS Japan to Integrate Celgene Next Year, HQ Relocation Planned in H1 2022: Chief
  August 3, 2020

• REGULATORY Pfizer to Supply COVID-19 Vaccine Doses for 60 Million People in Japan
  August 3, 2020

• BUSINESS Teva Takeda Narrowing Focus on Unique Generics, Eyes Innovative Meds: CEO
  July 31, 2020

• BUSINESS Nichi-Iko to Acquire Teva Takeda’s Generic Business
  July 30, 2020

• COMMENTARY With Equivocal Honebuto Wording, Off-Year Re-Pricing Debate Delayed Until Year-End
  July 30, 2020

• BUSINESS Pfizer Japan Has Different Interpretation on Lyrica Patent Ruling
  July 29, 2020

• BUSINESS Lyrica Expected to Face Generic Onslaught by Year’s End as Patent Ruled Invalid
  July 28, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 109
• 110
• 111
• 112
• 113
• 114
• 115
• 116
• 117
• …
• Next ›
• 最終 »